|Articles|October 1, 2019
- Pharmaceutical Executive-10-01-2019
- Volume 39
- Issue 10
Pharmaceutical Executive, October 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Tech Tour for the C-Suite: Pharma’s Digital Futureabout 6 years ago
It Starts with a Scribbleabout 6 years ago
Olivier Laureau, Servier: Free to Grow, Innovateabout 6 years ago
Corey McCann: A PDT Pioneerabout 6 years ago
Data Shape-Up: Striving to Standardizeabout 6 years ago
Policy Sync-Up: The Drug Importation Conundrumabout 6 years ago
Validating Value Data: AI and Outcomesabout 6 years ago
Underlying Platform: Data Unleashedabout 6 years ago
Surfing the Wave: The Patient-Data Puzzleabout 6 years ago
Where Does Europe’s Drug Industry Go from Here?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
4
FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
5
